Adrenomedullin in Ovarian cancer: Foe in vitro and friend in vivo?

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Baranello, Cinzia ^a   Mariani, Marisa ^b   Andreoli, Mirko ^b   Fanelli, Mara ^a   Martinelli, Enrica ^a   Ferrandina, Gabriella ^a   Scambia, Giovanni ^a   Shahabi, Shohreh ^a   Ferlini, Cristiano ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b DANBURY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN ANTAGONIST; ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CONTROL; CANCER PATIENT; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; NANOFLUIDICS; OVARY CANCER; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADENOCARCINOMA, PAPILLARY; ADRENOMEDULLIN; CA-125 ANTIGEN; CELL CYCLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84864486949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040678     Document Type: Article

References (25)

1. Huynh H, Zheng J, Umikawa M, Silvany R, Xie XJ, et al. ((2011)) Components of the hematopoietic compartments in tumor stroma and tumor-bearing mice. PLoS One 6:: e18054.
2. McAllister SS, Weinberg RA, ((2010)) Tumor-host interactions: a far-reaching relationship. J Clin Oncol 28:: 4022--4028.
3. Milliken D, Scotton C, Raju S, Balkwill F, Wilson J, ((2002)) Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res 8:: 1108--1114.
4. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, et al. ((1995)) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:: 2391--2396.
5. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, et al. ((2005)) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175:: 1197--1205.
6. Chen P, Huang Y, Bong R, Ding Y, Song N, et al. ((2011)) Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner. Clin Cancer Res 17:: 7230--7239.
7. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, et al. ((1993)) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:: 553--560.
8. Hinson JP, Kapas S, Smith DM, ((2000)) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:: 138--167.
9. Miksa M, Wu R, Cui X, Dong W, Das P, et al. ((2007)) Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma. J Immunol 179:: 6263--6272.
10. Smith DM, Coppock HA, Withers DJ, Owji AA, Hay DL, et al. ((2002)) Adrenomedullin: receptor and signal transduction. Biochem Soc Trans 30:: 432--437.
11. Beltowski J, Jamroz A, ((2004)) Adrenomedullin-what do we know 10 years since its discovery? Pol J Pharmacol 56:: 5--27.
12. Kyrgiou M, Salanti G, Pavlidis N, Paraskevaidis E, Ioannidis JP, ((2006)) Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst 98:: 1655--1663.
13. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, et al. ((2002)) Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 160:: 1279--1292.
14. Michelsen J, Thiesson H, Walter S, Ottosen PD, Skott O, et al. ((2006)) Tissue expression and plasma levels of adrenomedullin in renal cancer patients. Clin Sci (Lond) 111:: 61--70.
15. Keleg S, Kayed H, Jiang X, Penzel R, Giese T, et al. ((2007)) Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int J Cancer 121:: 21--32.
16. Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, et al. ((2009)) Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. Int J Cancer 125:: 2307--2315.
17. Hata K, Takebayashi Y, Akiba S, Fujiwaki R, Iida K, et al. ((2000)) Expression of the adrenomedullin gene in epithelial ovarian cancer. Mol Hum Reprod 6:: 867--872.
18. Giacalone PL, Daures JP, Ouafik L, Martin PM, Laffargue F, et al. ((2003)) Steroids and adrenomedullin growth patterns in human ovarian cancer cells: estrogenic-regulation assay. Gynecol Oncol 91:: 651--656.
19. Chen P, Pang X, Zhang Y, He Y (2012) Effect of inhibition of the adrenomedullin gene on the growth and chemosensitivity of ovarian cancer cells. Oncol Rep.
20. Biswas SK, Mantovani A, ((2010)) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:: 889--896.
21. Cho-Chung YS, ((1990)) Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 50:: 7093--7100.
22. Lucchi S, Calebiro D, de Filippis T, Grassi ES, Borghi MO, et al. ((2011)) 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms. PLoS One 6:: e20785.
23. De Donato M, Mariani M, Petrella L, Martinelli E, Zannoni GF, et al. ((2012)) Class III beta-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J Cell Physiol 227:: 1034--41.
24. Raspaglio G, Filippetti F, Prislei S, Penci R, De Maria I, et al. ((2008)) Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3′ flanking region. Gene 409:: 100--108.
25. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, et al. ((1996)) Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24:: 106--115.